START SAVING MONEY ON YOUR MEDICATIONS!
QUESTIONS? CALL
844-289-3981

Enroll in this premium prescription home delivery service, today!

For free delivery options, see FAQ section for details.

AZSol_PatientDirect_logo_V1

Powered by:
Truax Patient Services | Bemidji, MN 56601

PAY AS LITTLE AS $1.00 PER DAY* for ADTHYZA

PAY NO MORE THAN $1.50 A DAY* for EDARBI, EDARBYCLOR, or BiDil

PAY AS LITTLE AS $1.83 A DAY* for HORIZANT

*Does not include shipping fee on a 30-day supply.

Based on 90 tablets dispensed.

Based on once-daily dosing.

Please see accompanying full Prescribing Information, including Boxed Warning for Adthyza.

Please see Important Safety Information and Boxed Warnings for EDARBI and EDARBYCLOR.

Please see Important Safety Information for Horizant and Bidil.

Azurity Solutions - Patient Direct may be able to help with prescription medication access

Do you sometimes have difficulty affording your medication?

No insurance required. All patients are eligible.*

BrandMedication
Supply
Opt-Out-of-pocket Costs
For Standard Dosages
ADTHYZATM30 DAYS
90 DAYS
$35 plus shipping
$90 FREE SHIPPING
EDARBI®, EDARBYCLOR®, and BiDil®30 DAYS
90 DAYS
$40 plus shipping
$120 FREE SHIPPING
HORIZANT®30 TABLETS
90 TABLETS
$55 plus shipping
$165 FREE SHIPPING

Do you sometimes run out of or forget to fill your prescriptions?

Azurity Solutions - Patient Direct provides an auto-refill option.

Are you too busy to go to a retail pharmacy?

Home delivery saves you time.

*The cash discount prices listed are not valid for use with any prescription drug benefit plan. Azurity Solutions - Patient Direct applies only to eligible products from Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.

Getting started is simple and easy

step-1

You or your doctor sends the prescription to Truax Patient Services

step-2_V2.png

You can call 844-289-3981 to inquire about your prescription

step-3

Medication is delivered directly to your door

Phone: 844-289-3981

Fax: 218-444-2267

Frequently asked questions

You or your health care provider will send your prescription to be processed by the Azurity Solutions - Patient Direct partner organization, Truax Patient Services. You'll pay guaranteed cash pricing for your listed Azurity product prescriptions. See pricing above.

Information for Patients About ADTHYZATM

INDICATIONS:

ADTHYZATM (thyroid tablets, USP) is a prescription medicine indicated as replacement or supplemental therapy in patients with hypothyroidism of any etiology, except transient hypothyroidism during the recovery phase of subacute thyroiditis.

ADTHYZATM is also indicated as a pituitary TSH suppressant in the treatment or prevention of various types of euthyroid goiters, including thyroid nodules, subacute or chronic lymphocytic thyroiditis (Hashimoto’s), multinodular goiter, and in the management of thyroid cancer.

IMPORTANT SAFETY INFORMATION

WARNING: DRUGS WITH THYROID HORMONE ACTIVITY, ALONE OR TOGETHER WITH OTHER THERAPEUTIC AGENTS, HAVE BEEN USED FOR THE TREATMENT OF OBESITY. IN EUTHYROID PATIENTS, DOSES WITHIN THE RANGE OF DAILY HORMONAL REQUIREMENTS ARE INEFFECTIVE FOR WEIGHT REDUCTION. LARGER DOSES MAY PRODUCE SERIOUS OR EVEN LIFE THREATENING MANIFESTATIONS OF TOXICITY, PARTICULARLY WHEN GIVEN IN ASSOCIATION WITH SYMPATHOMIMETIC AMINES SUCH AS THOSE USED FOR THEIR ANORECTIC EFFECTS.

Do not use ADTHYZA in patients with uncorrected adrenal cortical insufficiency, untreated thyrotoxicosis (high thyroid hormone levels), and apparent hypersensitivity to any component of the product.

The use of thyroid hormones for weight loss, alone or combined with other drugs, is unjustified and has been shown to be ineffective. Neither is their use justified for the treatment of male or female infertility unless this condition is accompanied by low thyroid levels.

Thyroid hormones should be used with great caution in circumstances where the integrity of the cardiovascular system is suspected. In the elderly and in patients with cardiovascular disease, ADTHYZA should be used with greater caution.

Tell your doctor about any other medical conditions you may have, especially heart disease, diabetes, blood clotting problems, and adrenal or pituitary gland problems. The dose of other drugs you may be taking to control these conditions may have to be changed while you are taking.

A reportedly apparent association between prolonged thyroid therapy and breast cancer has not been confirmed, and patients on thyroid for established indications should not discontinue therapy. No confirmatory long-term studies in animals have been performed to evaluate cancer causing potential, mutagenicity, or impairment of fertility in either males or females.

Thyroid replacement therapy for hypothyroid women should not be discontinued during pregnancy, and hypothyroidism diagnosed during pregnancy should be promptly treated. Minimal amounts of thyroid hormones are excreted in human milk. However, caution should be exercised when thyroid is administered to a nursing woman. Routine determinations of serum T4 and/or TSH are strongly advised in neonates in view of the deleterious effects of thyroid deficiency on growth and development.

Tell your doctor immediately if you experience chest pain, increased pulse rate, rapid, strong, irregular heartbeat, excessive sweating, or any other unusual event.

Partial loss of hair may be experienced by children in the first few months of thyroid therapy, but this is usually a transient phenomenon.

Many drugs and some laboratory tests may alter your therapeutic response to ADTHYZA.

Tell your doctor about all medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take medicines to treat and prevent blood clots (anticoagulants), antidiabetic agents, or oral contraceptives.

For further information, please see the accompanying complete Prescribing Information for ADTHYZA.

To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1‐800‐461‐7449 or the FDA at www.fda.gov/medwatch or call 1‐800‐FDA‐1088.

 

Information for Patients About EDARBI and EDARBYCLOR

Indications for EDARBI and EDARBYCLOR

EDARBI and EDARBYCLOR are prescription medicines used to treat high blood pressure (hypertension). Your doctor may prescribe other medicines for you to take along with EDARBI or EDARBYCLOR to treat your high blood pressure. EDARBYCLOR is used when
one medicine is not enough or as the first medicine if your doctor decides you are likely to need more than one medicine. Medicines that lower your blood pressure may lower your chances of having a stroke or heart attack, but they don't work alone. It should be part of a complete treatment plan.

IMPORTANT SAFETY INFORMATION FOR EDARBI AND EDARBYCLOR

WARNING: EDARBI and EDARBYCLOR can cause harm or death to your unborn baby. If you become pregnant while taking EDARBI or EDARBYCLOR, tell your doctor right away. If you plan to become pregnant, talk to your doctor about other treatments to lower blood pressure.

  • Before taking EDARBI or EDARBYCLOR, tell your doctor if you are breastfeeding or plan to breastfeed. Discuss with your doctor other ways to lower your blood pressure. It is not known if EDARBYCLOR passes into breast milk. You and your doctor should decide if you will take EDARBI or EDARBYCLOR or breastfeed. You should not do both.
  • Do not take EDARBYCLOR if you make less urine because of kidney problems (anuria).
  • Do not take aliskiren-containing products with EDARBI or EDARBYCLOR if you have diabetes.
  • Tell your doctor about all your medical conditions, including if you have heart problems or stroke, have gout, or have liver or kidney problems. Kidney problems may become worse in people that already have kidney disease. If you have kidney problems, you may need blood tests, and your doctor may need to lower your dose or may need to stop treatment with EDARBYCLOR.
  • Tell your doctor about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your doctor if you take other medicines to treat your high blood pressure or heart problem; water pills (diuretics); lithium; or digoxin.
  • EDARBI and EDARBYCLOR may cause serious side-effects including low blood pressure (hypotension) which may cause you to feel faint and dizzy. Vomiting and diarrhea, a low salt diet, sweating a lot, or not drinking enough fluid can also lead to low blood pressure.
  • If you feel faint or dizzy, lie down and call your doctor right away. If you pass out (faint) have someone call your doctor or get medical help. Stop taking EDARBYCLOR.
  • If you have fluid and body salt (electrolytes) problems, tell your doctor if you experience any of the following symptoms: dry mouth, confusion, thirst, lack of energy/weakness, drowsiness, passing very little urine or passing large amounts of urine, seizures, muscle pain/cramps, restlessness, muscle tiredness (fatigue), fast or abnormal heartbeat, nausea and vomiting, or constipation.
  • People who have increased levels of uric acid in the blood may develop gout. If you already have gout tell your doctor about worsening of your gout symptoms.
  • In clinical studies, the most common side effect seen with EDARBI was diarrhea (2.0%).
  • In clinical studies, the side effects seen with EDARBYCLOR included dizziness (8.9%) and tiredness (2.0%).

You are encouraged to report side effects of prescription drugs to Azurity Pharmaceuticals, Inc., Medical Information at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

Please talk to your healthcare professional and see complete Prescribing Information for EDARBI and EDARBYCLOR.

 

Information for Patients About BiDil®

BiDil is approved for use with other heart medicines to treat heart failure in black patients to improve survival, improve heart failure symptoms, and help patients stay out of the hospital longer. There is little experience in patients with heart failure who experience significant symptoms while at rest. Most patients in the clinical study of BiDil also received other heart failure medicines.

IMPORTANT SAFETY INFORMATION

Tell your doctor about any allergies you have, especially if you're sensitive to nitrates, such as nitroglycerin tablets or isosorbide dinitrate (Isordil®). BiDil has a nitrate component, so you need to let your doctor know.

Tell your doctor if you're taking any erectile dysfunction or pulmonary hypertension drugs like Viagra® or Revatio (sildenafil), Levitra® (vardenafil) or Cialis® (tadalafil).

Warning and Precautions

Also tell your doctor if you are taking any medication to decrease blood pressure because when taken with BiDil, blood pressure may become too low.

It is possible you'll get headaches, especially at first, but they often lessen over time. Keep your doctor posted on your headache progress; he or she may want to adjust your dosage.

If you experience dizziness, call your doctor. Please make sure to tell your doctor about any of the signs or symptoms mentioned below or about any unusual events that worry you.

Drinking less fluids than your doctor recommends or losing fluid due to diarrhea, sweating, or vomiting may cause low blood pressure, lightheadedness, or fainting. If fainting occurs, stop taking BiDil and contact your doctor immediately.

Lightheadedness may occur when standing, especially after sitting or lying down.

If you experience any achy and/or swollen joints, unexplained fever for more than a few days, skin rashes, chest pain, prolonged weakness or fatigue (even after a good night's sleep), or any other unexplained signs or symptoms, make sure to tell your doctor as they may be signs of a serious medical condition.

You may also experience rapid heartbeat that could lead to chest pain or aggravate chest pain, or numbness or tingling in the hands or feet.

COMMON SIDE EFFECTS

Headache and dizziness were the most frequent side effects experienced in studies with BiDil.

Should read: You are encouraged to report side effects of prescription drugs to Azurity Pharmaceuticals, Inc., Medical Information at 1-800-461-7449 or to the FDA at www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information for BiDil. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Ask your doctor if BiDil may be right for you.

Important Safety Information for HORIZANT® (gabapentin enacarbil) Extended-Release Tablets (Patient ISI)

INDICATIONS

HORIZANT® (gabapentin enacarbil) is a prescription medicine used to:

  • treat adults with moderate to severe primary Restless Legs Syndrome (RLS). HORIZANT is not for people who need to sleep during the daytime and stay awake at night.
  • manage pain from damaged nerves (postherpetic neuralgia) that follows healing of shingles (a painful rash that comes after a herpes zoster infection) in adults.

IMPORTANT SAFETY INFORMATION

  • Do not drive after taking your dose of HORIZANT until you know how it affects you, including the morning after you take it. Do not operate heavy machinery or do other dangerous activities until you know how HORIZANT affects you. HORIZANT can cause sleepiness, dizziness, slow thinking, and can affect your coordination. Ask your healthcare provider when it is okay to do these activities.
  • Do not take other medicines that make you sleepy or dizzy while taking HORIZANT without talking to your healthcare provider. Taking HORIZANT with these other medicines may make your sleepiness or dizziness worse.
  • HORIZANT may cause suicidal thoughts or actions in a very small number of people (about 1 in 500). Pay attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings. Call your healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:
    • thoughts or actions about suicide, self-harm, or dying; attempt to commit suicide
    • new or worsening depression or anxiety; or feeling agitated
    • new or worse restlessness or panic attacks
    • new or worse trouble sleeping (insomnia); or irritability
    • acting aggressive, being angry, or violent; acting on dangerous impulses
    • an extreme increase in activity or talking (mania); other unusual changes in mood or behavior
  • Serious breathing problems. Serious breathing problems can occur when HORIZANT is taken with other medicines that can cause severe sleepiness or decreased awareness, or when it is taken by someone who already has breathing problems. Watch for increased sleepiness or decreased breathing when starting HORIZANT or when the dose is increased. Get help right away if breathing problems occur.
  • Do not stop taking HORIZANT without first talking to your healthcare provider. Suicidal thoughts or actions can be caused by things other than medicines. If you have these thoughts or actions, your healthcare provider may check for other causes.
  • HORIZANT may cause a serious or life-threatening allergic reaction that may affect your skin or other parts of your body such as your liver or blood cells. You may or may not have a rash with these types of reactions. Call a healthcare provider right away if you have any of the following symptoms: skin rash, hives, fever, swollen glands that do not go away, swelling of your lips or tongue, yellowing of your skin or eyes, unusual bruising or bleeding, severe fatigue or weakness, unexpected severe muscle pain, or frequent infections. These symptoms may be the first signs of a serious reaction. A healthcare provider should examine you to decide if you should continue taking HORIZANT.
  • HORIZANT is not the same medicine as gabapentin [for example, NEURONTIN® (gabapentin) and GRALISE® (gabapentin)]. HORIZANT should not be used in their place. Do not take these or other gabapentin products while taking HORIZANT.
  • Before taking HORIZANT, tell your healthcare provider if you:
    • have or have had kidney problems or are on hemodialysis
    • have or have had depression, mood problems, or suicidal thoughts or behavior
    • have or have had seizures
    • have a history of drug abuse
    • have any other medical conditions
    • are pregnant or plan to become pregnant. It is not known if HORIZANT will harm your unborn baby.
      Talk to your healthcare provider if you are pregnant or plan to become pregnant while taking HORIZANT.
      You and your healthcare provider will decide if you should take HORIZANT while you are pregnant
    • are breastfeeding or plan to breastfeed. Your body turns HORIZANT into another drug (gabapentin) that passes into your milk. It is not known if this can harm your baby. You and your healthcare provider should decide if you will take HORIZANT or breastfeed
    • drink alcohol
  • Do not drink alcohol while taking HORIZANT because it may increase the risk of side effects.
  • Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Taking HORIZANT with certain other medicines can cause side effects or affect how well they work. Do not start or stop other medicines without talking to your healthcare provider.
  • Do not stop taking HORIZANT without talking to your healthcare provider first. If you stop taking HORIZANT suddenly, you may develop side effects.
  • The most common side effects of HORIZANT include dizziness, sleepiness, and headache. Tell your healthcare provider about any side effect that bothers you or does not go away. These are not all the possible side effects of HORIZANT. For more information, ask your healthcare provider or pharmacist.


You are encouraged to report side effects of prescription drugs by contacting Azurity Pharmaceuticals, Inc.
at 1-800-461-7449, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.

For more information, ask your healthcare provider or pharmacist, or consult the full Prescribing Information [Horizant.com].

The information you supply will be provided to Truax Patient Services, a company administering Azurity Solutions - Patient Direct on behalf of Arbor Pharmaceuticals, LLC (a subsidiary of Azurity Pharmaceuticals, Inc.) for the purpose of fulfilling your prescription. Personal health information will not be rented or sold and will be secured. Truax Patient Services may use this information to contact your healthcare provider or insurance provider for information relevant to this request.

 

1200x450_AZ_Logo_White-300x113-1.png

 

Edarbi or Edarbyclor is exclusively marketed in the United States by Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.

Edarbi and Edarbyclor are trademarks of Takeda Pharmaceutical Company Limited registered with the U.S. Patent and Trademark Office and used under license by Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.

BiDil and HORIZANT are each registered trademarks of Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.

Trademarks are the property of their respective owners.

This site is intended for use by U.S. residents only.

© 2023 Arbor Pharmaceuticals, LLC, a subsidiary of Azurity Pharmaceuticals, Inc.

Download full Prescribing Information for AdthyzaTM, Edarbi®Edarbyclor®BiDil® and HORIZANT®

Privacy PolicyContact Us

PP-ADZ-US-0042